Institutional & Family Asset Management, LLC Kodiak Sciences Inc. Transaction History

Institutional & Family Asset Management, LLC

$846 Million
Q2 2024

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$80.85 - $128.49 $404 - $642	-5 Closed	0 $0
Q3 2021 Nov 10, 2021	SELL	$81.97 - $106.94 $245 - $320	-3 Reduced 37.5%	5 $0
Q1 2021 May 06, 2021	SELL	$110.45 - $164.47 $552 - $822	-5 Reduced 38.46%	8 $1,000
Q4 2020 Feb 03, 2021	BUY	$60.78 - $154.03 $790 - $2,002	13 New	13 $2,000

Others Institutions Holding KOD

# of Institutions

Shares Held

39M

Call Options Held

6.5K

Put Options Held

5.8K

Baker Bros. Advisors LP New York, NY

17.3M
Shares

$158 Million
0.48% of portfolio
Black Rock Inc. New York, NY

3.85M
Shares

$35.1 Million
0.0% of portfolio
Acadian Asset Management LLC Boston, MA

1.95M
Shares

$17.8 Million
0.02% of portfolio
Vanguard Group Inc Valley Forge, PA

1.69M
Shares

$15.4 Million
0.0% of portfolio
Iconiq Capital, LLC San Francisco, CA

1.02M
Shares

$9.27 Million
0.06% of portfolio

View Full List

About Kodiak Sciences Inc.

Ticker KOD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 52,040,200
Market Cap $475M
Description
Kodiak Sciences Inc., a clinical stage biopharmaceutical company, researches, develops, and commercializes therapeutics to treat retinal diseases. Its lead product candidate is KSI-301, an anti-vascular endothelial growth factor antibody biopolymer that is in Phase IIb/III clinical study to treat wet age-related macular degeneration (AMD), as we...

More about KOD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Institutional & Family Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Institutional & Family Asset Management, LLC with notifications on news.

Account